What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
Clive Ballard spends much of his time researching Dementia, Psychiatry, Alzheimer's disease, Dementia with Lewy bodies and Internal medicine.
His work carried out in the field of Dementia brings together such families of science as Central nervous system disease and Degenerative disease.
His work deals with themes such as Placebo and Randomized controlled trial, which intersect with Psychiatry.
His Alzheimer's disease research includes themes of Stroke, REM sleep behavior disorder, Cholinesterase and Quality of life.
His research in Dementia with Lewy bodies intersects with topics in Lewy body, Braak staging, Audiology, Parkinsonism and Neuroscience.
As a part of the same scientific family, Clive Ballard mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Nicotinic agonist.
His most cited work include:
- Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop (3554 citations)
- Dementia prevention, intervention, and care (2073 citations)
What are the main themes of his work throughout his whole career to date?
Dementia, Psychiatry, Disease, Dementia with Lewy bodies and Internal medicine are his primary areas of study.
The study incorporates disciplines such as Alzheimer's disease, Randomized controlled trial and Central nervous system disease in addition to Dementia.
His Psychiatry research includes elements of Memantine and Clinical psychology.
His Disease study incorporates themes from Clinical trial, Bioinformatics and Intensive care medicine.
Clive Ballard interconnects Pediatrics, Neuroscience, Parkinson's disease and Parkinsonism in the investigation of issues within Dementia with Lewy bodies.
His biological study spans a wide range of topics, including Placebo, Endocrinology, Oncology and Cardiology.
He most often published in these fields:
- Dementia (62.84%)
- Psychiatry (37.05%)
- Disease (25.23%)
What were the highlights of his more recent work (between 2018-2021)?
- Dementia (62.84%)
- Disease (25.23%)
- Cognition (12.95%)
In recent papers he was focusing on the following fields of study:
Clive Ballard focuses on Dementia, Disease, Cognition, Clinical psychology and Internal medicine.
His Dementia research is multidisciplinary, relying on both Gerontology, Quality of life, Intervention, Psychiatry and Randomized controlled trial.
The Psychiatry study which covers Epidemiology that intersects with Stroke.
His Disease research is mostly focused on the topic Lewy body.
His study in Clinical psychology is interdisciplinary in nature, drawing from both Cognitive skill, Effects of sleep deprivation on cognitive performance, Anxiety, Cognitive decline and Depression.
His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo and Endocrinology.
Between 2018 and 2021, his most popular works were:
- Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. (1376 citations)
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. (303 citations)
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Clive Ballard mainly investigates Dementia, Disease, Clinical trial, Cognition and Psychological intervention.
Particularly relevant to Dementia with Lewy bodies is his body of work in Dementia.
Clive Ballard combines subjects such as Biomarker, Psychiatry, Psychosis and Neuroscience with his study of Disease.
His study looks at the relationship between Psychiatry and topics such as Cohort, which overlap with Retrospective cohort study.
His Clinical trial study combines topics from a wide range of disciplines, such as Drug development, Parkinson's disease, Clinical significance, Neuroimaging and Visual Hallucination.
His Cognition study combines topics in areas such as Publication bias, Clinical psychology and Repeated measures design.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
